Verrica Pharmaceuticals Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Jun 2017 | — | — | $506.0K |
| Sep 2017 | — | — | $396.0K |
| Dec 2017 | $616.0K | $9.1M | $8.7M |
| Mar 2018 | — | — | $27.5M |
| Jun 2018 | $3.1M | $104.7M | $103.1M |
| Sep 2018 | $2.5M | $98.8M | $38.3M |
| Dec 2018 | $2.5M | $91.9M | $10.3M |
| Mar 2019 | $3.2M | $86.0M | $24.4M |
| Jun 2019 | $4.4M | $81.3M | $19.9M |
| Sep 2019 | $4.4M | $76.1M | $10.6M |
| Dec 2019 | $3.4M | $68.4M | $9.2M |
| Mar 2020 | $37.8M | $94.4M | $54.5M |
| Jun 2020 | $38.8M | $87.2M | $48.9M |
| Sep 2020 | $40.8M | $79.9M | $17.2M |
| Dec 2020 | $41.2M | $74.2M | $10.7M |
| Mar 2021 | $46.3M | $108.1M | $44.1M |
| Jun 2021 | $46.9M | $99.0M | $24.7M |
| Sep 2021 | $47.9M | $88.8M | $20.4M |
| Dec 2021 | $47.5M | $80.1M | $15.8M |
| Mar 2022 | $46.2M | $71.6M | $10.4M |
| Jun 2022 | $47.1M | $63.4M | $5.4M |
| Sep 2022 | $4.4M | $49.1M | $32.5M |
| Dec 2022 | $4.7M | $44.7M | $34.3M |
| Mar 2023 | $3.8M | $68.6M | $60.0M |
| Jun 2023 | $6.8M | $62.2M | $55.1M |
| Sep 2023 | $54.8M | $97.1M | $84.3M |
| Dec 2023 | $61.8M | $81.6M | $69.5M |
| Mar 2024 | $64.8M | $66.3M | $48.9M |
| Jun 2024 | $65.3M | $52.0M | $31.9M |
| Sep 2024 | $67.0M | $32.9M | $23.0M |
| Dec 2024 | $64.0M | $54.1M | $46.3M |
| Mar 2025 | $60.8M | $42.2M | $29.6M |
| Jun 2025 | $56.6M | $39.1M | $15.4M |
| Sep 2025 | $57.9M | $40.9M | $21.1M |
| Dec 2025 | $22.4M | $47.1M | $30.1M |
| Mar 2026 | $22.7M | $38.8M | $20.6M |
| Jun 2026 | $31.7M | $36.0M | $11.2M |